Adipokines in neurovascular diseases

Radka Opatrilova, Martin Caprnda, Peter Kubatka, Vanda Valentova, Sona Uramova, Vladimir Nosal, Ludovit Gaspar, Lukas Zachar, Ioana Mozos, Daniel Petrovic, Jozef Dragasek, Slavomira Filipova, Dietrich Busselberg, Anthony Zulli, Luis Rodrigo, Peter Kruzliak, Vladimir Krasnik

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Adipose tissue is now described as an endocrine organ secreting a number of adipokines contributing to the development of inflammation and metabolic imbalance, but also endothelial dysfunction, vascular remodeling, atherosclerosis, and ischemic stroke. Leptin, adiponectin, and resistin are the most studied adipokines which play important roles in the regulation of cardiovascular homeostasis. Leptin and adiponectin mediate both proatherogenic and antiatherogenic responses. Leptin and adiponectin have been linked to the development of coronary heart disease and may be involved in the underlying biological mechanism of ischemic stroke. Resistin, a pro-inflammatory cytokine, is predictive of atherosclerosis and poor clinical outcomes in patients with coronary artery disease and ischemic stroke. The changes in serum levels of novel adipokines apelin, visfatin are also associated with acute ischemic stroke. These adipokines have been proposed as potential prognostic biomarkers of cardiovascular mortality/morbidity and therapeutic targets in patients with cardiometabolic diseases. In this article, we summarize the biologic role of the adipokines and discuss the link between dysfunctional adipose tissue and metabolic/inflammation imbalance, consequently endothelial damage, progression of atherosclerotic disease, and the occurrence of ischemic stroke.

Original languageEnglish
Pages (from-to)424-432
Number of pages9
JournalBiomedicine and Pharmacotherapy
Volume98
DOIs
Publication statusPublished - 1 Feb 2018

Fingerprint

Adipokines
Stroke
Adiponectin
Leptin
Resistin
Adipose Tissue
Atherosclerosis
Nicotinamide Phosphoribosyltransferase
Inflammation
Coronary Disease
Disease Progression
Coronary Artery Disease
Homeostasis
Biomarkers
Cytokines
Morbidity
Mortality
Serum

Keywords

  • Adipokines
  • Adiponectin
  • Apelin
  • Atherosclerosis
  • Inflammation
  • Ischemic stroke
  • Leptin
  • Metabolic changes
  • Resistin
  • Visfatin

ASJC Scopus subject areas

  • Pharmacology

Cite this

Opatrilova, R., Caprnda, M., Kubatka, P., Valentova, V., Uramova, S., Nosal, V., ... Krasnik, V. (2018). Adipokines in neurovascular diseases. Biomedicine and Pharmacotherapy, 98, 424-432. https://doi.org/10.1016/j.biopha.2017.12.074

Adipokines in neurovascular diseases. / Opatrilova, Radka; Caprnda, Martin; Kubatka, Peter; Valentova, Vanda; Uramova, Sona; Nosal, Vladimir; Gaspar, Ludovit; Zachar, Lukas; Mozos, Ioana; Petrovic, Daniel; Dragasek, Jozef; Filipova, Slavomira; Busselberg, Dietrich; Zulli, Anthony; Rodrigo, Luis; Kruzliak, Peter; Krasnik, Vladimir.

In: Biomedicine and Pharmacotherapy, Vol. 98, 01.02.2018, p. 424-432.

Research output: Contribution to journalReview article

Opatrilova, R, Caprnda, M, Kubatka, P, Valentova, V, Uramova, S, Nosal, V, Gaspar, L, Zachar, L, Mozos, I, Petrovic, D, Dragasek, J, Filipova, S, Busselberg, D, Zulli, A, Rodrigo, L, Kruzliak, P & Krasnik, V 2018, 'Adipokines in neurovascular diseases', Biomedicine and Pharmacotherapy, vol. 98, pp. 424-432. https://doi.org/10.1016/j.biopha.2017.12.074
Opatrilova R, Caprnda M, Kubatka P, Valentova V, Uramova S, Nosal V et al. Adipokines in neurovascular diseases. Biomedicine and Pharmacotherapy. 2018 Feb 1;98:424-432. https://doi.org/10.1016/j.biopha.2017.12.074
Opatrilova, Radka ; Caprnda, Martin ; Kubatka, Peter ; Valentova, Vanda ; Uramova, Sona ; Nosal, Vladimir ; Gaspar, Ludovit ; Zachar, Lukas ; Mozos, Ioana ; Petrovic, Daniel ; Dragasek, Jozef ; Filipova, Slavomira ; Busselberg, Dietrich ; Zulli, Anthony ; Rodrigo, Luis ; Kruzliak, Peter ; Krasnik, Vladimir. / Adipokines in neurovascular diseases. In: Biomedicine and Pharmacotherapy. 2018 ; Vol. 98. pp. 424-432.
@article{9866a61fc89344d697e1f51cd7574887,
title = "Adipokines in neurovascular diseases",
abstract = "Adipose tissue is now described as an endocrine organ secreting a number of adipokines contributing to the development of inflammation and metabolic imbalance, but also endothelial dysfunction, vascular remodeling, atherosclerosis, and ischemic stroke. Leptin, adiponectin, and resistin are the most studied adipokines which play important roles in the regulation of cardiovascular homeostasis. Leptin and adiponectin mediate both proatherogenic and antiatherogenic responses. Leptin and adiponectin have been linked to the development of coronary heart disease and may be involved in the underlying biological mechanism of ischemic stroke. Resistin, a pro-inflammatory cytokine, is predictive of atherosclerosis and poor clinical outcomes in patients with coronary artery disease and ischemic stroke. The changes in serum levels of novel adipokines apelin, visfatin are also associated with acute ischemic stroke. These adipokines have been proposed as potential prognostic biomarkers of cardiovascular mortality/morbidity and therapeutic targets in patients with cardiometabolic diseases. In this article, we summarize the biologic role of the adipokines and discuss the link between dysfunctional adipose tissue and metabolic/inflammation imbalance, consequently endothelial damage, progression of atherosclerotic disease, and the occurrence of ischemic stroke.",
keywords = "Adipokines, Adiponectin, Apelin, Atherosclerosis, Inflammation, Ischemic stroke, Leptin, Metabolic changes, Resistin, Visfatin",
author = "Radka Opatrilova and Martin Caprnda and Peter Kubatka and Vanda Valentova and Sona Uramova and Vladimir Nosal and Ludovit Gaspar and Lukas Zachar and Ioana Mozos and Daniel Petrovic and Jozef Dragasek and Slavomira Filipova and Dietrich Busselberg and Anthony Zulli and Luis Rodrigo and Peter Kruzliak and Vladimir Krasnik",
year = "2018",
month = "2",
day = "1",
doi = "10.1016/j.biopha.2017.12.074",
language = "English",
volume = "98",
pages = "424--432",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",

}

TY - JOUR

T1 - Adipokines in neurovascular diseases

AU - Opatrilova, Radka

AU - Caprnda, Martin

AU - Kubatka, Peter

AU - Valentova, Vanda

AU - Uramova, Sona

AU - Nosal, Vladimir

AU - Gaspar, Ludovit

AU - Zachar, Lukas

AU - Mozos, Ioana

AU - Petrovic, Daniel

AU - Dragasek, Jozef

AU - Filipova, Slavomira

AU - Busselberg, Dietrich

AU - Zulli, Anthony

AU - Rodrigo, Luis

AU - Kruzliak, Peter

AU - Krasnik, Vladimir

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Adipose tissue is now described as an endocrine organ secreting a number of adipokines contributing to the development of inflammation and metabolic imbalance, but also endothelial dysfunction, vascular remodeling, atherosclerosis, and ischemic stroke. Leptin, adiponectin, and resistin are the most studied adipokines which play important roles in the regulation of cardiovascular homeostasis. Leptin and adiponectin mediate both proatherogenic and antiatherogenic responses. Leptin and adiponectin have been linked to the development of coronary heart disease and may be involved in the underlying biological mechanism of ischemic stroke. Resistin, a pro-inflammatory cytokine, is predictive of atherosclerosis and poor clinical outcomes in patients with coronary artery disease and ischemic stroke. The changes in serum levels of novel adipokines apelin, visfatin are also associated with acute ischemic stroke. These adipokines have been proposed as potential prognostic biomarkers of cardiovascular mortality/morbidity and therapeutic targets in patients with cardiometabolic diseases. In this article, we summarize the biologic role of the adipokines and discuss the link between dysfunctional adipose tissue and metabolic/inflammation imbalance, consequently endothelial damage, progression of atherosclerotic disease, and the occurrence of ischemic stroke.

AB - Adipose tissue is now described as an endocrine organ secreting a number of adipokines contributing to the development of inflammation and metabolic imbalance, but also endothelial dysfunction, vascular remodeling, atherosclerosis, and ischemic stroke. Leptin, adiponectin, and resistin are the most studied adipokines which play important roles in the regulation of cardiovascular homeostasis. Leptin and adiponectin mediate both proatherogenic and antiatherogenic responses. Leptin and adiponectin have been linked to the development of coronary heart disease and may be involved in the underlying biological mechanism of ischemic stroke. Resistin, a pro-inflammatory cytokine, is predictive of atherosclerosis and poor clinical outcomes in patients with coronary artery disease and ischemic stroke. The changes in serum levels of novel adipokines apelin, visfatin are also associated with acute ischemic stroke. These adipokines have been proposed as potential prognostic biomarkers of cardiovascular mortality/morbidity and therapeutic targets in patients with cardiometabolic diseases. In this article, we summarize the biologic role of the adipokines and discuss the link between dysfunctional adipose tissue and metabolic/inflammation imbalance, consequently endothelial damage, progression of atherosclerotic disease, and the occurrence of ischemic stroke.

KW - Adipokines

KW - Adiponectin

KW - Apelin

KW - Atherosclerosis

KW - Inflammation

KW - Ischemic stroke

KW - Leptin

KW - Metabolic changes

KW - Resistin

KW - Visfatin

UR - http://www.scopus.com/inward/record.url?scp=85038847621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038847621&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2017.12.074

DO - 10.1016/j.biopha.2017.12.074

M3 - Review article

VL - 98

SP - 424

EP - 432

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

ER -